Actinic keratosis: a case report
DOI:
https://doi.org/10.35954/SM2016.35.2.5Keywords:
Keratosis Actinic, Carcinoma Squamous Cell, Skin Neoplasms, Sunscreening Agents, Ultraviolet RaysAbstract
The clinical history of a 78-year-old woman, phototype III according to Fitzpatrick's classification, who was exposed to the sun for a long time and presented skin with marked actinic damage evidenced by abundant actinic lentigines; she developed disseminated actinic keratoses in the neckline, lower limbs, upper limbs and face.
Based on this history and having consulted the corresponding bibliography, the clinical, etiopathogenic, epidemiologic, anatomopathologic characteristics and treatments of actinic keratoses are presented, as well as guidelines for their prevention.
Downloads
Metrics
References
(1) Hernandez Osorio C, Fuentes Palma B, CartesVelasquez R. Queilitis actínica: aspectos histológicos, clínicos y epidemiológicos. Rev Cubana Estomatol 2016; 53(2):45-55.
(2) Moy RL. Clinical presentation of actinic keratoses and squamous cell carcinoma. J Am Acad Dermatol 2000; 42(1 Pt 2):8-10.
(3) Schwartz RA. Premalignant keratinocytic neoplasms. J Am Acad Dermatol 1996; 35(2 Pt 1):223-42.
(4) Marks R. Who benefits from calling a solar keratosis a squamous cell carcinoma? Br J Dermatol 2006; 155(1):23-6.
(5) Ciudad C, Aviles J, Suarez R, Lázaro P. Utilidad de la dermatoscopia en el diagnóstico de las queratosis actínicas pigmentadas. Actas Dermosifilogr 2011; 102(8):623-626.
(6) Rigel D, Cockerell C, Carucci J, Wharton J. Queratosis Actínica, Carcinoma Basocelular y Carcinoma Espinocelular. Cap. 108. En: Bolognia J, Jorizzo J, Rapini R, editores. Dermatología. 2a.ed. Madrid : Mosby, Elsevier, 2004, p.1641-1660.
(7) Yu R, Pryce D, Macfarlane A, Stewart T. A histopathological study of 643 cutaneous horns. Br J Dermatol 1991; 124(5):449-52.
(8) Pellacani G, Ulrich M, Casari A, Prow T, Cannillo F, Benati E, et al. Grading keratinocyte atypia in actinic keratosis: a correlation of reflectance confocal microscopy and histopathology. J Eur Acad Dermatol Venereol 2015; 29(11):2216-21.
(9) Dinehart SM, Nelson-Adesokarn P, Cockerell C, Russell S, Brown R. Metastatic cutaneous squamous cell carcinoma derived from actinic keratosis. Cancer 1997; 79(5):920-3.
(10) Glogau R. The risk of progression to invasive disease. J Am Acad Dermatol 2000; 42(1 Pt 2):23-4.
(11) Hurtwitz RM, Monger LE. Solar keratosis an evolving squamoius cell carcinoma, benign or malignant? Dermatol Surg Oncol 1995; 21(2):184.
(12) Fikamizu H, Inoue K, Matsumoto K, Okayama H, Moriguchi T. Metastatic squamous cell carcinoma derived from solar keratosis. J Dermatol Surg Oncol 1985; 11(5):518-22.
(13) Lebwohl M.Queratosis actínica. JAMA2016; 315(13):1394-95.
(14) Gilberto Y, Aguilar M, Almagro M, Correia O, Guillen C, Harto A, et al. Documento de consenso hispanoportugués para el uso de la terapia fotodinámica con metil aminolevulinato y luz de día en el tratamiento de las queratosis actínicas. Actas dermosifilográficas 2015; 106(8):623-631.
(15) Chen A, Martin A, Choy B, Fernández-Peñas P, Dalziell R, McKenzie C, et al. A phase 3 randomized trial of nicotiamide for skin-cancer chemoprevention. N Engl J Med 2015; 373(17):1618-26.
(16) Ianhez M, Froes L, Miot H, Bagatin E. Retinoides para a prevenção e tratamento das queratoses actínicas. An Bras Dermatol 2013; 88(4):585-93.
Published
How to Cite
Issue
Section
License
Until 2024 we use the Creative Commons Attribution/NonCommercial Attribution 4.0 International License https://creativecommons.org/licenses/by-nc/4.0/deed.es. Which states that: you are free to share, copy and redistribute the material in any medium or format, as well as to adapt, remix, transform and build upon the material. Under the following terms:
Attribution: you must give proper credit , provide a link to the license, and indicate if changes have been made . You may do so in any reasonable manner, but not in such a way as to suggest that you or your use is endorsed by the licensor.
NonCommercial: you may not use the material for commercial purposes.
As of 2025 authors retain their copyright and assign to the journal the right of first publication of their work, which shall simultaneously be subject to the license https://creativecommons.org/licenses/by-nc-sa/4.0/deed.es that permits sharing, copying and redistribution of the material in any medium or format provided that initial publication in this journal is indicated. Adapt, remix, transform and build upon the material. If you remix, transform, or build from the material, you must distribute your contribution under the same license as the original and may not make use of the material for commercial purposes.
Under the following terms:
1. Attribution: you must give proper credit, provide a link to the license, and indicate whether changes have been made. You may do so in any reasonable manner, but not in such a way as to suggest that you or your use is endorsed by the licensor.
2. NonCommercial: you may not use the material for commercial purposes.
3. ShareAlike: if you remix, transform or build upon the material, you must distribute your contribution under the same license as the original.
PlumX Metrics
/
